DRUG · Mapped RxNorm record
capecitabine
Normalized identity: capecitabineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00010023
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
cisplatin
Normalized identity: cisplatinView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Cancerverified · MONDO: cancer
Interventions
capecitabineDRUG · verified · RxNorm: capecitabine
cisplatinDRUG · verified · RxNorm: cisplatin
Sponsors & collaborators
NYU Langone Healthlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00010023 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.